Get the Stockscreener App
1.40
3.78%
-0.055
After Hours:
1.39
-0.01
-0.71%
Neuronetics Inc stock is traded at $1.40, with a volume of 883.38K.
It is down -3.78% in the last 24 hours and up +4.48% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$1.455
Open:
$1.48
24h Volume:
883.38K
Relative Volume:
0.47
Market Cap:
$96.99M
Revenue:
$149.16M
Net Income/Loss:
$-39.14M
P/E Ratio:
-2.3427
EPS:
-0.5976
Net Cash Flow:
$-21.18M
1W Performance:
+3.70%
1M Performance:
+4.48%
6M Performance:
-47.57%
1Y Performance:
-67.96%
1-Day Range:
$1.3701
$1.50
1-Week Range:
$1.195
$1.65
52-Week Range:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.40 | 100.80M | 149.16M | -39.14M | -21.18M | -0.5976 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook - MyChesCo
Neuronetics (NASDAQ:STIM) Director Sells $62,027.26 in Stock - MarketBeat
Neuronetics (NASDAQ:STIM) EVP Steven Pfanstiel Sells 16,431 Shares - MarketBeat
Neuronetics appoints Dan Reuvers as CEO, succeeding Keith Sullivan - MSN
Published on: 2026-03-25 12:08:27 - baoquankhu1.vn
Top Neuronetics Insiders Quietly Unload a Wave of Shares in Rapid-Fire Moves - TipRanks
Neuronetics EVP Macan sells $21k in shares By Investing.com - Investing.com South Africa
Neuronetics: former officer Sullivan sells $62k in shares By Investing.com - Investing.com South Africa
Neuronetics EVP Pfanstiel sells $22k in shares By Investing.com - Investing.com Australia
Neuronetics EVP Pfanstiel sells $22k in shares - Investing.com
Neuronetics: former officer Sullivan sells $62k in shares - Investing.com
Neuronetics EVP Macan sells $21k in shares - Investing.com
Neuronetics (STIM) CFO Pfanstiel sells 16,431 shares to cover tax withholding - Stock Titan
Neuronetics (STIM) ex-officer sells 46,289 shares to cover tax withholding - Stock Titan
Neuronetics (STIM) EVP Macan sells 16,005 shares to cover RSU tax - Stock Titan
Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan - MyChesCo
Layoff Watch: Does Neuronetics Inc have pricing power2026 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Neuronetics (STIM) CEO awarded 1,500,000 restricted stock units in equity grant - Stock Titan
Neuronetics (STIM) CEO Daniel Reuvers named as insider in Form 3 - Stock Titan
Insider Buying: Jorey Chernett Acquires Additional Shares of Neu - GuruFocus
Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Buys $238,955.52 in Stock - MarketBeat
Chernett Jorey buys Neuronetics (STIM) shares worth $238,955 By Investing.com - Investing.com Australia
Chernett Jorey buys Neuronetics (STIM) shares worth $238,955 - Investing.com
Major Neuronetics (NASDAQ: STIM) holder adds 169K shares - Stock Titan
Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher (STIM) - Seeking Alpha
Malvern’s Neuronetics Announces New CEO as 2025 Revenue Nearly Doubles to $149M - BUCKSCO.Today
Neuronetics (NASDAQ:STIM) Stock Rating Lowered by Wall Street Zen - MarketBeat
Major Investor Makes Bold Move Into Neuronetics Stock - TipRanks
Form 144 Neuronetics For: 19 March By Investing.com - Investing.com Australia
Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Acquires $819,990.00 in Stock - MarketBeat
Jorey Chernett Buys 450,000 Shares of Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Insider Buying: Jorey Chernett Acquires 1,057,400 Shares of Neur - GuruFocus
Chernett Jorey buys Neuronetics (STIM) shares worth $1.42 million - Investing.com UK
Neuronetics 10% Owner Purchased Shares Worth Over $1.4M - TradingView
Chernett Jorey buys Neuronetics (STIM) shares worth $1.42 million By Investing.com - Investing.com Australia
Neuronetics Insider Bought Shares Worth $1,418,490, According to a Recent SEC Filing - marketscreener.com
Neuronetics (NASDAQ: STIM) 10% holder buys 1,057,400 shares - Stock Titan
STIM (NASDAQ: STIM) Form 144: insider resale notice for 16,005 shares - Stock Titan
STIM (NASDAQ: STIM) notice: proposed sale of 46,289 common shares - Stock Titan
Canaccord Genuity Group Lowers Neuronetics (NASDAQ:STIM) Price Target to $3.00 - MarketBeat
STIM: Neuronetics Analyst Rating UpdateMarch 19, 2026 | STIM Stock News - GuruFocus
Neuronetics, Inc. (NASDAQ:STIM) Q4 2025 Earnings Call Transcript - Insider Monkey
Form 144 Neuronetics For: 19 March - Investing.com
[Form 4] Neuronetics, Inc. Insider Trad... - Stock Titan
Neuronetics (STIM) EVP receives 33,750 performance-based common shares - Stock Titan
Neuronetics (STIM) CFO awarded 25,000 RSUs vesting from 2027 - Stock Titan
This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain - AOL.com
Neuronetics to Spotlight Expanding Mental Health Therapies at Major Industry Forum - MSN
Canaccord cuts Neuronetics stock price target on valuation shift By Investing.com - Investing.com India
Neuronetics (NASDAQ:STIM) Major Shareholder Acquires 531,000 Shares - MarketBeat
Insider Buying: Jorey Chernett Acquires 531,000 Shares of Neuron - GuruFocus
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):